Inmune Bio (INMB) Asset Utilization Ratio (2021 - 2025)
Inmune Bio's Asset Utilization Ratio came in at 0.00 for Q4 2025, up 401.9% from 0.00 a year earlier and up 8.1% from the prior quarter.
Powered by 
Analysis
Inmune Bio (INMB) Asset Utilization Ratio (2021 - 2025) Analysis & Trends
Going back to Q1 2021, Inmune Bio's Asset Utilization Ratio data covers 20 quarters.
- Going back by year, Asset Utilization Ratio was 0.00 in FY2024 (-87.0%), 0.00 in FY2023 (-45.7%), 0.00 in FY2022 (+59.9%) and 0.00 in FY2021 (+662.2%).
- The Q4 2025 figure represents the highest quarterly Asset Utilization Ratio since Q2 2024.
- Year-over-year, Asset Utilization Ratio increased in two of the last eight quarters, with growth averaging 20.6%.
- The fastest year-over-year change in Asset Utilization Ratio over five years came in Q4 2025 (growth of 401.9%), and the weakest in Q4 2024 (a decline of 88.3%).
- Business Quant data shows INMB's Asset Utilization Ratio at 0.00 (Q3 2025), 0.00 (Q2 2025) and 0.00 (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 0.62 |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 0.49 |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 0.47 |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 0.52 |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 0.46 |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 0.51 |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 0.40 |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 0.58 |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 0.31 |
| 10 | Inmune Bio | 42.88 Mn | -49.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 0.00 |
| Mar 31, 2021 | 0.00 |
API Access
Inmune Bio Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=INMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "INMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=INMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();